+

AU2001261360A1 - R-eliprodil for treating glaucoma - Google Patents

R-eliprodil for treating glaucoma

Info

Publication number
AU2001261360A1
AU2001261360A1 AU2001261360A AU6136001A AU2001261360A1 AU 2001261360 A1 AU2001261360 A1 AU 2001261360A1 AU 2001261360 A AU2001261360 A AU 2001261360A AU 6136001 A AU6136001 A AU 6136001A AU 2001261360 A1 AU2001261360 A1 AU 2001261360A1
Authority
AU
Australia
Prior art keywords
eliprodil
treating glaucoma
glaucoma
treating
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001261360A
Inventor
Michael V. W. Bergamini
Michael A. Kapin
Verney L. Sallee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Universal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Universal Ltd filed Critical Alcon Universal Ltd
Publication of AU2001261360A1 publication Critical patent/AU2001261360A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Methods for treating glaucoma with R-eliprodil alone and in combination with other agents for treating glaucoma are disclosed.
AU2001261360A 2000-05-10 2001-05-09 R-eliprodil for treating glaucoma Abandoned AU2001261360A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20335000P 2000-05-10 2000-05-10
US60203350 2000-05-10
PCT/US2001/015074 WO2001085152A2 (en) 2000-05-10 2001-05-09 R-eliprodil for treating glaucoma

Publications (1)

Publication Number Publication Date
AU2001261360A1 true AU2001261360A1 (en) 2001-11-20

Family

ID=22753611

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001261360A Abandoned AU2001261360A1 (en) 2000-05-10 2001-05-09 R-eliprodil for treating glaucoma
AU2001263042A Abandoned AU2001263042A1 (en) 2000-05-10 2001-05-10 R-eliprodil for treating glaucoma

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001263042A Abandoned AU2001263042A1 (en) 2000-05-10 2001-05-10 R-eliprodil for treating glaucoma

Country Status (7)

Country Link
EP (1) EP1280528B1 (en)
JP (1) JP2004521065A (en)
AT (1) ATE291425T1 (en)
AU (2) AU2001261360A1 (en)
CA (1) CA2406549A1 (en)
DE (1) DE60109594D1 (en)
WO (2) WO2001085152A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005502678A (en) * 2001-08-29 2005-01-27 アルコン，インコーポレイテッド Use of compounds to treat LASIK and other conditions resulting from corneal nerve injury or trauma after surgery
US6884816B2 (en) 2001-08-31 2005-04-26 Alcon, Inc. Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
AU2003300915B2 (en) 2002-12-13 2008-08-28 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
US7476687B2 (en) 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
TW200520760A (en) 2003-12-15 2005-07-01 Alcon Inc Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2628740B3 (en) * 1989-04-12 1990-01-19 Synthelabo PROCESS FOR THE PREPARATION OF (CHLORO-4 PHENYL) -1 (((FLUORO-4 PHENYL) METHYL) -4 PIPERIDYL-1) -2-ETHANOL ENANTIOMERS
FR2654341B1 (en) * 1989-11-14 1994-09-23 Synthelabo USE OF IFENPRODIL AND DERIVATIVES THEREOF FOR THE MANUFACTURE OF ANTIPSYCHOTIC DRUGS.
US5710165A (en) * 1994-07-06 1998-01-20 Synthelabo Use of polyamine antagonists for the treatment of glaucoma
EP0861079A1 (en) * 1995-11-17 1998-09-02 Alcon Laboratories, Inc. Combination therapy for treating glaucoma
EP1100491A1 (en) * 1998-07-21 2001-05-23 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
CA2337399A1 (en) * 1998-07-21 2000-02-03 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension

Also Published As

Publication number Publication date
AU2001263042A1 (en) 2001-11-20
EP1280528B1 (en) 2005-03-23
EP1280528A2 (en) 2003-02-05
WO2001085169A3 (en) 2002-03-28
DE60109594D1 (en) 2005-04-28
WO2001085169A2 (en) 2001-11-15
CA2406549A1 (en) 2001-11-15
JP2004521065A (en) 2004-07-15
WO2001085152A2 (en) 2001-11-15
ATE291425T1 (en) 2005-04-15
WO2001085152A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
IL144406A0 (en) Anticonvulsant derivatives useful in treating cluster headaches
WO2004030627A3 (en) Synergistic methods and compositions for treating cancer
ZA200106160B (en) Compositions and methods for treating cataracts.
WO2004087075A3 (en) Compositions and methods for treating cancer
AU2001261752A1 (en) Compositions and methods for treating otic, ophthalmic and nasal infections
AU2002355419A1 (en) Methods and compositions for treating diseases associated with excesses in ace
AU2002328972A1 (en) Piperidine derivatives as antibacterial agents
IL157333A0 (en) Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
HU9503605D0 (en) Use of nona- and decapeptides in the preparation of a drug for the treatment of aids
AU2002222287A1 (en) Piperazine derivatives for treatment of bacterial infections
AU2001245437A1 (en) Lightweight methods and compositions for well treating
WO2002072022A3 (en) Substituted tetracycline compounds as antifungal agents
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
AU2003284242A1 (en) Methods and compositions for use in treating cancer
MY138285A (en) Fab i inhibitors
GB9917406D0 (en) Compounds
AU2001268564A1 (en) Alpha-glycosylceramides for treating bacterial and fungal infections
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
WO2002076499A3 (en) Combination treatment of pancreatic cancer
AU2001282399A1 (en) Resorcinol derivatives
AU143942S (en) Controller device
AU2001253495A1 (en) Treating graft rejection with ccr5 inhibitors
AU2001261360A1 (en) R-eliprodil for treating glaucoma
WO2002024179A3 (en) Method for reducing toxicity of combined chemotherapies
AU2001280093A1 (en) Method for the prevention and treatment of retinopathy
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载